PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo.
Saved in:
| Title: | PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo. |
|---|---|
| Authors: | Peng, Haisheng1 (AUTHOR), Chai, Yanqun2 (AUTHOR), Gong, Chen2 (AUTHOR), Hao, Yue1,3 (AUTHOR), Peng, Yanbo4 (AUTHOR), Zhang, Wenyuan2 (AUTHOR), Liu, Xiaoying2 (AUTHOR), Tang, Shukun2 (AUTHOR), Kong, Qingfei3 (AUTHOR) kqfangel@hrbmu.edu.cn, Wang, Qun5 (AUTHOR) qunwang@iastate.edu |
| Source: | Bioengineering & Translational Medicine. Jul2026, Vol. 11 Issue 4, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 195039102 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Peng%2C+Haisheng%22">Peng, Haisheng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Chai%2C+Yanqun%22">Chai, Yanqun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gong%2C+Chen%22">Gong, Chen</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hao%2C+Yue%22">Hao, Yue</searchLink><relatesTo>1,3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Peng%2C+Yanbo%22">Peng, Yanbo</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhang%2C+Wenyuan%22">Zhang, Wenyuan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Liu%2C+Xiaoying%22">Liu, Xiaoying</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tang%2C+Shukun%22">Tang, Shukun</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kong%2C+Qingfei%22">Kong, Qingfei</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> kqfangel@hrbmu.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Wang%2C+Qun%22">Wang, Qun</searchLink><relatesTo>5</relatesTo> (AUTHOR)<i> qunwang@iastate.edu</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Bioengineering+%26+Translational+Medicine%22">Bioengineering & Translational Medicine</searchLink>. Jul2026, Vol. 11 Issue 4, p1-16. 16p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=195039102 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/btm2.70144 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 16 StartPage: 1 Titles: – TitleFull: PEGylated thymosin β4 is a thiol‐site‐specific prodrug treating myocardial infarction in vivo. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peng, Haisheng – PersonEntity: Name: NameFull: Chai, Yanqun – PersonEntity: Name: NameFull: Gong, Chen – PersonEntity: Name: NameFull: Hao, Yue – PersonEntity: Name: NameFull: Peng, Yanbo – PersonEntity: Name: NameFull: Zhang, Wenyuan – PersonEntity: Name: NameFull: Liu, Xiaoying – PersonEntity: Name: NameFull: Tang, Shukun – PersonEntity: Name: NameFull: Kong, Qingfei – PersonEntity: Name: NameFull: Wang, Qun IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: Jul2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 23806761 Numbering: – Type: volume Value: 11 – Type: issue Value: 4 Titles: – TitleFull: Bioengineering & Translational Medicine Type: main |
| ResultId | 1 |